Data will be collected before treatment, 72 hours after treatment, and at the end of treatment according to evaluation criteria. After 30 days of treatment, outpatient or telephone follow-up will be conducted for each patient. Detailed follow-up information can not be collected to record the reasons for loss of follow-up information. All data will be collected by one or two assistants. Personal information about potential and registered participants will be collected, shared, and kept in a separate storeroom to protect confidentiality before, during, and after the trial. Access to the database will be limited to the researchers of this research group.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.